HCM.GB

HUTCHMED China (HCM.GB)

HUTCHMED China Limited

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AQSE:HCM.GB

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/12/29	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/12/29	17 : 30	UK Regulatory	Hutchmed (China) Limited Blocklisting Six Monthly Return	AQSE:HCM.GB	HUTCHMED China Limited
2023/12/21	19 : 00	UK Regulatory	Hutchmed (China) Limited Overseas Regulatory Announcement	AQSE:HCM.GB	HUTCHMED China Limited
2023/12/07	19 : 04	UK Regulatory	Hutchmed (China) Limited Overseas Regulatory Announcement	AQSE:HCM.GB	HUTCHMED China Limited
2023/11/30	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/11/09	16 : 00	UK Regulatory	Hutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)	AQSE:HCM.GB	HUTCHMED China Limited
2023/10/24	17 : 30	UK Regulatory	Hutchmed (China) Limited Vesting of awards under the LTIP	AQSE:HCM.GB	HUTCHMED China Limited
2023/09/29	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/09/14	17 : 30	UK Regulatory	Hutchmed (China) Limited Director's Share Dealing	AQSE:HCM.GB	HUTCHMED China Limited
2023/08/31	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/08/21	15 : 00	UK Regulatory	Hutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary Endpoint	AQSE:HCM.GB	HUTCHMED China Limited
2023/08/07	17 : 30	UK Regulatory	Hutchmed (China) Limited Exercise of Share Options by a Director	AQSE:HCM.GB	HUTCHMED China Limited
2023/07/31	20 : 00	UK Regulatory	Hutchmed (China) Limited Interim Results and Business Updates	AQSE:HCM.GB	HUTCHMED China Limited
2023/07/13	17 : 30	UK Regulatory	Hutchmed (China) Limited Changes to Board and Technical Committee	AQSE:HCM.GB	HUTCHMED China Limited
2023/06/29	17 : 30	UK Regulatory	Hutchmed (China) Limited Blocklisting Six Monthly Return	AQSE:HCM.GB	HUTCHMED China Limited
2023/06/26	17 : 30	UK Regulatory	Hutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year Results	AQSE:HCM.GB	HUTCHMED China Limited
2023/06/16	15 : 00	UK Regulatory	Hutchmed (China) Limited Phase III FRESCO-2 Results in The Lancet	AQSE:HCM.GB	HUTCHMED China Limited
2023/06/15	23 : 39	UK Regulatory	Hutchmed (China) Limited MAA of Fruquintinib Validated by the EMA	AQSE:HCM.GB	HUTCHMED China Limited
2023/06/06	18 : 00	UK Regulatory	Hutchmed (China) Limited LTIP and Share Option Scheme	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/31	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/26	15 : 00	UK Regulatory	Hutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDA	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/17	17 : 30	UK Regulatory	Hutchmed (China) Limited Standard form for notification of major holdings	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/12	21 : 15	UK Regulatory	Hutchmed (China) Limited Annual General Meeting Poll Results	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/12	17 : 30	UK Regulatory	Hutchmed (China) Limited Board of Directors and Board Committee Membership	AQSE:HCM.GB	HUTCHMED China Limited
2023/05/10	17 : 30	UK Regulatory	Hutchmed (China) Limited Appointment of Independent NED	AQSE:HCM.GB	HUTCHMED China Limited
2023/04/28	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited
2023/04/21	17 : 30	UK Regulatory	Hutchmed (China) Limited Vesting of awards under the LTIP	AQSE:HCM.GB	HUTCHMED China Limited
2023/04/11	17 : 30	UK Regulatory	Hutchmed (China) Limited 2022 Annual Report and Notice of AGM	AQSE:HCM.GB	HUTCHMED China Limited
2023/04/11	17 : 30	UK Regulatory	Hutchmed (China) Limited Intended Retirement of Independent NED	AQSE:HCM.GB	HUTCHMED China Limited
2023/03/31	17 : 30	UK Regulatory	Hutchmed (China) Limited Total Voting Rights	AQSE:HCM.GB	HUTCHMED China Limited